赞比亚女性性工作者HIV自检的整群随机对照试验
在赞比亚三个城市开展整群随机对照试验,965名女性性工作者随机分为直接发放口腔HIV自检试剂、领取优惠券到诊所/药房取试剂或标准检测三组。主要结局为1个月和4个月自报HIV检测率,直接发放组1个月检测率94.9%,与标准检测组无显著差异;HIV自检可接受且可及,但在检测和转介已较高的环境中可能不会大幅增加HIV服务链条进展。
要点
- 直接发放组1个月HIV检测率94.9%,与标准检测组88.5%相比无显著差异(RR=1.07,95%CI 0.99-1.15,P=0.10)。
- 直接发放组1个月自检使用率高于优惠券组(RR=1.14,95%CI 1.05-1.23,P=0.001),4个月时无差异。
- 1个月和4个月时,两个HIV自检组阳性者转介治疗率较标准检测组非显著降低。
核心结论
- 在赞比亚女性性工作者中,HIV自检可接受且可及,但在检测和转介已较高的环境中可能不会大幅增加HIV服务链条进展。
研究设计与样本
- 在赞比亚Kapiri Mposhi、Chirundu和Livingstone开展的整群随机对照试验,2016年9月16日至10月12日共纳入965名女性性工作者,直接发放组N=316、优惠券组N=329、标准检测组N=320。
- 由培训过的同伴教育者招募参与者,每组同伴教育者-女性性工作者组合随机分配至三种干预之一。
- 两个HIV自检组在基线和10周各获得2个口腔自检试剂,参与者在1个月和4个月时完成问卷。
主要发现
- 1个月HIV检测率:直接发放组94.9%,优惠券组84.4%,标准检测组88.5%;直接发放组vs标准检测组RR=1.07(95%CI 0.99-1.15,P=0.10),优惠券组vs标准检测组RR=0.95(95%CI 0.86-1.05,P=0.29),直接发放组vs优惠券组RR=1.13(95%CI 1.04-1.22,P=0.005)。
- 4个月HIV检测率:直接发放组84.1%,优惠券组79.8%,标准检测组75.1%;直接发放组vs标准检测组RR=1.11(95%CI 0.98-1.27,P=0.11),优惠券组vs标准检测组RR=1.06(95%CI 0.92-1.22,P=0.42),直接发放组vs优惠券组RR=1.05(95%CI 0.94-1.18,P=0.40)。
- 1个月时大多数HIV检测为自检(88.4%);直接发放组1个月自检使用率高于优惠券组(RR=1.14,95%CI 1.05-1.23,P=0.001),4个月时无差异。
- 在1个月(N=144)和4个月(N=235)报告HIV阳性检测结果的参与者中,两个HIV自检组转介治疗率较标准检测组非显著降低。
- 共有4例与研究参与相关的亲密伴侣暴力事件,其中3例与HIV自检使用相关。
关键数值与推荐
- 主要结局为1个月和4个月访视时过去一个月内自报的任何HIV检测。
- 次要结局包括转介治疗、HIV自检组中自检使用及不良事件。
- 入组时20%的参与者从未检测过HIV。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究结局为自报性质。
- HIV检测总体接受度较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HIV self-testing (HIVST) may play a role in addressing gaps in HIV testing coverage and as an entry point for HIV prevention services. We conducted a cluster randomized trial of 2 HIVST distribution mechanisms compared to the standard of care among female sex workers (FSWs) in Zambia. METHODS AND FINDINGS: Trained peer educators in Kapiri Mposhi, Chirundu, and Livingstone, Zambia, each recruited 6 FSW participants. Peer educator-FSW groups were randomized to 1 of 3 arms: (1) delivery (direct distribution of an oral HIVST from the peer educator), (2) coupon (a coupon for collection of an oral HIVST from a health clinic/pharmacy), or (3) standard-of-care HIV testing. Participants in the 2 HIVST arms received 2 kits: 1 at baseline and 1 at 10 weeks. The primary outcome was any self-reported HIV testing in the past month at the 1- and 4-month visits, as HIVST can replace other types of HIV testing. Secondary outcomes included linkage to care, HIVST use in the HIVST arms, and adverse events. Participants completed questionnaires at 1 and 4 months following peer educator interventions. In all, 965 participants were enrolled between September 16 and October 12, 2016 (delivery, N = 316; coupon, N = 329; standard of care, N = 320); 20% had never tested for HIV. Overall HIV testing at 1 month was 94.9% in the delivery arm, 84.4% in the coupon arm, and 88.5% in the standard-of-care arm (delivery versus standard of care risk ratio [RR] = 1.07, 95% CI 0.99-1.15, P = 0.10; coupon versus standard of care RR = 0.95, 95% CI 0.86-1.05, P = 0.29; delivery versus coupon RR = 1.13, 95% CI 1.04-1.22, P = 0.005). Four-month rates were 84.1% for the delivery arm, 79.8% for the coupon arm, and 75.1% for the standard-of-care arm (delivery versus standard of care RR = 1.11, 95% CI 0.98-1.27, P = 0.11; coupon versus standard of care RR = 1.06, 95% CI 0.92-1.22, P = 0.42; delivery versus coupon RR = 1.05, 95% CI 0.94-1.18, P = 0.40). At 1 month, the majority of HIV tests were self-tests (88.4%). HIV self-test use was higher in the delivery arm compared to the coupon arm (RR = 1.14, 95% CI 1.05-1.23, P = 0.001) at 1 month, but there was no difference at 4 months. Among participants reporting a positive HIV test at 1 (N = 144) and 4 months (N = 235), linkage to care was non-significantly lower in the 2 HIVST arms compared to the standard-of-care arm. There were 4 instances of intimate partner violence related to study participation, 3 of which were related to HIV self-test use. Limitations include the self-reported nature of study outcomes and overall high uptake of HIV testing. CONCLUSIONS: In this study among FSWs in Zambia, we found that HIVST was acceptable and accessible. However, HIVST may not substantially increase HIV cascade progression in contexts where overall testing and linkage are already high. TRIAL REGISTRATION: ClinicalTrials.gov NCT02827240.
引用
- Chanda MM, Ortblad KF, Mwale M, et al. HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial. PLoS Med. 2017. PMID: 29161260. doi:10.1371/journal.pmed.1002442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。